Geode Capital Management’s NRC Health Common Stock NRC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $9.06M | Buy |
420,056
+26,209
| +7% | +$487K | ﹤0.01% | 2607 |
|
|
2026
Q1 | $6.69M | Buy |
393,847
+10,336
| +3% | +$176K | ﹤0.01% | 2597 |
|
|
2025
Q4 | $7.2M | Sell |
383,511
-20,886
| -5% | -$315K | ﹤0.01% | 2570 |
|
|
2025
Q3 | $5.17M | Buy |
404,397
+99
| +0% | +$1.49K | ﹤0.01% | 2760 |
|
|
2025
Q2 | $6.79M | Sell |
404,298
-42,275
| -9% | -$571K | ﹤0.01% | 2572 |
|
|
2025
Q1 | $5.72M | Buy |
446,573
+10,866
| +2% | +$174K | ﹤0.01% | 2595 |
|
|
2024
Q4 | $7.69M | Buy |
435,707
+14,974
| +4% | +$284K | ﹤0.01% | 2523 |
|
|
2024
Q3 | $9.62M | Buy |
420,733
+13,039
| +3% | +$295K | ﹤0.01% | 2404 |
|
|
2024
Q2 | $9.36M | Buy |
407,694
+38,079
| +10% | +$1.17M | ﹤0.01% | 2359 |
|
|
2024
Q1 | $14.6M | Buy |
369,615
+13,310
| +4% | +$526K | ﹤0.01% | 2100 |
|
|
2023
Q4 | $14.1M | Buy |
356,305
+18,227
| +5% | +$763K | ﹤0.01% | 2128 |
|
|
2023
Q3 | $15M | Buy |
338,078
+14,892
| +5% | +$650K | ﹤0.01% | 2009 |
|
|
2023
Q2 | $14.1M | Buy |
323,186
+14,750
| +5% | +$649K | ﹤0.01% | 2089 |
|
|
2023
Q1 | $13.4M | Buy |
308,436
+4,291
| +1% | +$189K | ﹤0.01% | 2074 |
|
|
2022
Q4 | $11.3M | Buy |
304,145
+6,945
| +2% | +$269K | ﹤0.01% | 2179 |
|
|
2022
Q3 | $11.8M | Buy |
297,200
+5,969
| +2% | +$221K | ﹤0.01% | 2112 |
|
|
2022
Q2 | $11.1M | Buy |
291,231
+25,463
| +10% | +$921K | ﹤0.01% | 2169 |
|
|
2022
Q1 | $10.5M | Buy |
265,768
+11,681
| +5% | +$457K | ﹤0.01% | 2316 |
|
|
2021
Q4 | $10.5M | Buy |
254,087
+1,744
| +0.7% | +$75.8K | ﹤0.01% | 2408 |
|
|
2021
Q3 | $10.6M | Buy |
252,343
+3,523
| +1% | +$177K | ﹤0.01% | 2420 |
|
|
2021
Q2 | $11.4M | Buy |
248,820
+11,496
| +5% | +$547K | ﹤0.01% | 2366 |
|
|
2021
Q1 | $11.1M | Buy |
237,324
+21,770
| +10% | +$1.06M | ﹤0.01% | 2286 |
|
|
2020
Q4 | $9.21M | Sell |
215,554
-487
| -0.2% | -$25K | ﹤0.01% | 2235 |
|
|
2020
Q3 | $10.6M | Buy |
216,041
+2,553
| +1% | +$141K | ﹤0.01% | 1904 |
|
|
2020
Q2 | $12.4M | Buy |
213,488
+21,266
| +11% | +$1.12M | ﹤0.01% | 1802 |
|
|
2020
Q1 | $8.74M | Buy |
192,222
+11,035
| +6% | +$663K | ﹤0.01% | 1815 |
|
|
2019
Q4 | $11.9M | Buy |
181,187
+645
| +0.4% | +$39.4K | ﹤0.01% | 1887 |
|
|
2019
Q3 | $10.4M | Buy |
180,542
+6,283
| +4% | +$389K | ﹤0.01% | 1904 |
|
|
2019
Q2 | $10M | Buy |
174,259
+19,856
| +13% | +$919K | ﹤0.01% | 1953 |
|
|
2019
Q1 | $5.96M | Buy |
154,403
+18,097
| +13% | +$709K | ﹤0.01% | 2228 |
|
|
2018
Q4 | $5.2M | Sell |
136,306
-2,287
| -2% | -$87.9K | ﹤0.01% | 2199 |
|
|
2018
Q3 | $5.35M | Buy |
138,593
+29,825
| +27% | +$1.13M | ﹤0.01% | 2318 |
|
|
2018
Q2 | $4.07M | Buy |
108,768
+10,961
| +11% | +$382K | ﹤0.01% | 2446 |
|
|
2018
Q1 | $2.86M | Buy |
97,807
+5,111
| +6% | +$171K | ﹤0.01% | 2571 |
|
|
2017
Q4 | $3.46M | Buy |
92,696
+3,191
| +4% | +$113K | ﹤0.01% | 2438 |
|
|
2017
Q3 | $3.37M | Buy |
89,505
+16,424
| +22% | +$516K | ﹤0.01% | 2439 |
|
|
2017
Q2 | $1.97M | Buy |
73,081
+5,639
| +8% | +$138K | ﹤0.01% | 2740 |
|
|
2017
Q1 | $1.33M | Buy |
67,442
+10,891
| +19% | +$201K | ﹤0.01% | 2877 |
|
|
2016
Q4 | $1.07M | Buy |
56,551
+206
| +0.4% | +$3.4K | ﹤0.01% | 2953 |
|
|
2016
Q3 | $917K | Buy |
56,345
+785
| +1% | +$12.3K | ﹤0.01% | 2983 |
|
|
2016
Q2 | $761K | Buy |
55,560
+753
| +1% | +$10.6K | ﹤0.01% | 3028 |
|
|
2016
Q1 | $852 | Buy |
54,807
+2,503
| +5% | +$36.7K | ﹤0.01% | 2969 |
|
|
2015
Q4 | $838K | Buy |
52,304
+347
| +0.7% | +$5.27K | ﹤0.01% | 3009 |
|
|
2015
Q3 | $620K | Buy |
51,957
+2,498
| +5% | +$33.2K | ﹤0.01% | 3120 |
|
|
2015
Q2 | $702K | Buy |
49,459
+3,694
| +8% | +$52.3K | ﹤0.01% | 3062 |
|
|
2015
Q1 | $659K | Buy |
45,765
+4,081
| +10% | +$57.7K | ﹤0.01% | 3068 |
|
|
2014
Q4 | $583K | Buy |
41,684
+216
| +0.5% | +$3.17K | ﹤0.01% | 3118 |
|
|
2014
Q3 | $539K | Buy |
41,468
+3,268
| +9% | +$44.9K | ﹤0.01% | 3130 |
|
|
2014
Q2 | $534K | Buy |
38,200
+623
| +2% | +$9.37K | ﹤0.01% | 3135 |
|
|
2014
Q1 | $623K | Buy |
37,577
+91
| +0.2% | +$1.52K | ﹤0.01% | 3049 |
|
|
2013
Q4 | $705K | Buy |
37,486
+911
| +2% | +$16K | ﹤0.01% | 2912 |
|
|
2013
Q3 | $689K | Buy |
36,575
+1,141
| +3% | +$19.6K | ﹤0.01% | 2787 |
|
|
2013
Q2 | $638K | Buy |
+35,434
| New | +$566K | ﹤0.01% | 2733 |
|
Other funds holding NRC
WIC
QI
FMII
Geode Capital Management's NRC Position: Q2 2026 in Review
Geode Capital Management increased its NRC Health Common Stock (NRC) stake by 6.7% in Q2 2026, buying an estimated $487K and bringing the position to 420,056 shares worth $9.06M. The position accounts for ﹤0.01% of the portfolio, ranked #2607.
Geode Capital Management first reported a position in NRC in Q2 2013 and has held it in 53 quarters since. The position peaked at $15M in Q3 2023. 123 funds tracked by Wall St. Rank hold NRC as of Q2 2026.
- Geode Capital Management held 420,056 shares of NRC Health Common Stock worth $9.06M as of Q2 2026.
- Geode Capital Management bought 26,209 NRC Health Common Stock shares in Q2 2026, an estimated $487K.
- NRC Health Common Stock made up ﹤0.01% of Geode Capital Management's portfolio in Q2 2026, its #2607 holding.
- Geode Capital Management first reported a position in NRC Health Common Stock in Q2 2013 and has held it in 53 quarters since.
- Geode Capital Management's NRC Health Common Stock position peaked at $15M in Q3 2023.
- 123 funds tracked by Wall St. Rank held NRC Health Common Stock as of Q2 2026.
Based on Geode Capital Management's 13F filing for Q2 2026, filed 12 Aug 2026.